Effects of α2-adrenergic agonism, imidazolines, and G-protein on insulin secretion in β cells

Metabolism: Clinical and Experimental

Volumn 46, Issue 10, 1997, Pages 1146-1149

  Hirose, Hiroshi ^a,b   Seto, Yoshiko ^a   Maruyama, Hiroshi ^a   Dan, Katsuaki ^a   Nakamura, Keiko ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4,5 TETRAHYDRO 2 (2 IMIDAZOLIN 2 YL) 2 PROPYLPYRROLO[3,2,1 HI]INDOLE; 1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; GLUCOSE; IMIDAZOLINE DERIVATIVE; INSULIN; MIDAGLIZOLE; OXYMETAZOLINE; PERTUSSIS TOXIN; PHENTOLAMINE;

ALPHA ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG MECHANISM; HAMSTER; INSULIN RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030882284     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90207-9     Document Type: Article

References (23)

1. Woods SC, Porte DJ: The central nervous system, pancreatic hormones, feeding, and obesity. Adv Metab Dis 9:282-312, 1978
2. Miller RE: Pancreatic neuroendocrinology: Peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocr Rev 4:471-494, 1981
3. Nakadate T, Nakaki T, Muraki T, et al: Adrenergic regulation of blood glucose levels: Possible involvement of postsynaptic alpha-2 type adrenergic receptors regulating insulin release. J Pharmacol Exp Ther 215:226-230, 1980
4. Nakaki T, Nakadate T, Kato R: α2-Adrenoceptors modulating insulin release from isolated pancreatic islets. Naunyn Schmiedebergs Arch Pharmacol 313:151-153, 1980
5. Koyama K, Hirose H, Maruyama H, et al: Arachidonic acid metabolites and α2-adrenoceptor-mediated glucagon secretion in rats. Diabetes Res Clin Pract 16:229-232, 1992
6. Hirose H, Maruyama H, Itoh K, et al: Alpha-2 adrenergic agonism stimulates islet glucagon release from perfused rat pancreas: Possible involvement of alpha-2A adrenergic receptor subtype. Acta Endocrinol (Copenh) 127:279-283, 1992
7. Hirose H, Maruyama H, Ito K, et al: Effects of α2- and β-adrenergic agonism on glucagon secretion from perfused pancreata of normal and streptozotocin-induced diabetic rats. Metabolism 42:1072-1076, 1993
8. Metz SA, Halter JB, Robertson RP: Induction of defective insulin secretion and impaired glucose tolerance by clonidine: Selective stimulation of metabolic alpha-adrenergic pathways. Diabetes 27:554-562, 1978
9. Kawazu S, Suzuki M, Negishi K, et al: Studies of midaglizole (DG-5128): A new type of oral hypoglycemic drug in healthy subjects. Diabetes 36:216-220, 1987
10. Ortiz-Alonso FJ, Herman WH, Gertz BJ, et al: Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus. Metabolism 40:1161-1167, 1991
11. Berlin I, Rosenzweig P, Chalon S, et al: Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects. Clin Pharmacol Ther 55:338-345, 1994
12. Schulz A, Hasselblatt A: An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 340:321-327, 1989
13. + channels in mouse pancreatic beta-cells. Br J Pharmacol 101:115-120, 1990
14. Henquin JC, Charles S, Nenquin M, et al: Diazoxide and D600 inhibition of insulin release: Distinct mechanisms explain the specificity for different stimuli. Diabetes 31:776-783, 1982
15. Chan SLF, Morgan NG: Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. Eur J Pharmacol 176:97-101, 1990
16. ATP channels in insulin secreting cells. Eur J Pharmacol 204:41-48, 1991
17. Chan SLF, Stillings MR, Morgan NG: Mechanisms involved in stimulation of insulin secretion by the hypoglycaemic alpha-adrenergic antagonist, DG-5128. Biochem Biophys Res Commun 176:1545-1551, 1991
18. Remaury A, Herve P: The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxanbinding sites. J Pharmacol Exp Ther 260:417-426, 1992
19. Chan SL, Brown CA, Scarpello KE, et al: Pancreatic beta-cells express an imidazoline binding site that is distinct from I1 and I2 sites. Ann NY Acad Sci 763:153-156, 1995
20. Morgan NG, Chan SL, Brown CA, et al: Characterization of the imidazoline binding site involved in regulation of insulin secretion. Ann NY Acad Sci 763:361-373, 1995
21. Seaquist ER, Neal AR, Shoger KD, et al: G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes 41:1390-1399, 1992
22. Hirose H, Maruyama H, Seto Y, et al: Effects of D-phenylalaninederivative hypoglycemic agent A-4166 on pancreatic α- and β-cells: Comparative study with glibenclamide. Pharmacology 50:175-181, 1995
23. Morgan NG, Pallett AL, Mourtada M, et al: Synthesis and characterisation of KU14R, a novel antagonist of the pancreatic islet imidazoline binding site. Diabetologia 39:A121, 1996 (suppl 1, abstr)